TREATMENT OF TICS IN TOURETTES SYNDROME WITH ARIPIPRAZOLE

  • Mohan Chawla Consultant Psychiatrist, Clarendon House, 8-12, Station Road, Kettering, Northantoms, NN15 7HH, UK
  • Ashok Kumar Jainer The Caludon Centre, Walsgrave Hospital, Coventry, CV2 2TE, UK.
  • Zoreh Fouladi Senior House Officer, The Caludon Centre, Walsgrave Hospital, Coventry, CV2 2TE, UK.

Abstract

We report a case of 59 year old man who was suffering from tics since the age of 5 but when he came to the services for depressive symptoms at the age of 45, he came to the attention and was diagnosed as a case of Tourettes syndrome with co morbid depression.

Downloads

Download data is not yet available.

References

1. Mukkades NM, Abali O. Quetiapine treatment of children and adolescents with Tourette‘s disorder. Child Adoles Psychopharmacol 2003; 13:295-9.
2. McGvin JK, Goa L. Aripiprazol. CNS Drugs 2002; 16:79-86.
3. Kastrup A, Schlotter W, Plewnia C, Barteis M. Treatment of tics in Tourette syndrome with aripiprazole. J Clin Psychiatry 2005; 25:94-6.
4. McLen AJ. The use of the dopamine-receptor partial agonist aripiprazole in the treatment of restless legs syndrome. Sleep 2004; 27:1022.
5. Connor KM, Payne VM, Gadde KM, Zhang W, Davidson JR. The use of aripiprazole in obsessive-compulsive patients: preliminary observations in 8
patients. J Clin Psychiatry 2005; 66:49-51.
Published
2008-12-31
How to Cite
1.
Chawla M, Jainer AK, Fouladi Z. TREATMENT OF TICS IN TOURETTES SYNDROME WITH ARIPIPRAZOLE. J Pak Psychiatr Soc [Internet]. 2008Dec.31 [cited 2024Nov.22];5(2):118-9. Available from: https://jpps.pk/index.php/journal/article/view/632
Issue
Vol 5 No 2 (2008): Journal of Pakistan Psychiatric Society
Section
Case Report

Copyright © JPPS. Published by Pakistan Psychiatric Society

Licensing: This work is licensed under Creative Commons Attribution-NonCommercial 4.0 International License

Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purposes. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.